Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. - Wikidata - awgldk - TriplyDB

Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.

Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.

http://www.wikidata.org/entity/Q33343858

about

Platelet count, spleen length, and platelet count/spleen length ratio for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosis Human platelets and their capacity of binding viruses: meaning and challenges?Risk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus Infection The pathogenesis of immune thrombocytopaenic purpura Thrombocytopenia and infections.Platelet count increase following phlebotomy in iron overloaded patients with liver cirrhosis.Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1.Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia.Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients.Autoimmune thrombocytopenia related to chronic hepatitis C virus infection.Pathobiology of secondary immune thrombocytopenia.The ITP syndrome: pathogenic and clinical diversity.Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy.Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection.Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag.Interferon-alpha induced severe thrombocytopenia: a case report and review of the literature.Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis Pathobiology and treatment of hepatitis virus-related thrombocytopenia.Prevalence, severity, and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy.Romiplostim in the management of thrombocytopenia in a patient with autoimmune hepatitis.Immunological HCV-associated thrombocytopenia: short review Immunological alterations in hepatitis C virus infection.The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Management of thrombocytopenia in advanced liver disease Therapeutic efficacy of splenectomy is attenuated by necroinflammation of the liver in patients with liver cirrhosis.Hepatitis C virus infection among patients with chronic immune thrombocytopenic purpura in northern India.Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial.Management of Hepatitis C Antiviral Therapy Adverse Effects.Platelet count/bipolar spleen diameter ratio for the prediction of esophageal varices: The special Egyptian situation: Noninvasive prediction of esophageal varices.The human microbiome in hematopoiesis and hematologic disorders.Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection The management of side-effects during therapy for hepatitis C.UKHCDO guidelines on the management of HCV in patients with hereditary bleeding disorders 2011.Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.Immune thrombocytopenic purpura might be an early hematologic manifestation of undiagnosed human immunodeficiency virus infection.Role of hematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients.Higher hepatitis C [correction of hepatis C ] virus concentration in platelets than in plasma in a patient with ITP.

P2860

Q24234737-8CA3DA6A-7275-4BD0-870C-8F1F0481C2C5 Q26997803-D826EA91-58EB-472A-A37C-6D32171FE4C8 Q27490427-5D264786-2898-40FA-856A-83EE0444840F Q28236898-713921D0-5285-452A-BD87-7F9157142BD3 Q30240119-4ABB71DD-A46C-40A0-A6D8-A9A205A569F4 Q33349456-74EE7E8E-1401-4BA1-8F04-ED304ECCBAC5 Q33362537-2D21EDD7-06CA-42F0-B0A1-4D223BBBE477 Q33368703-C5EED28F-239B-447D-B1B9-E46893A176BB Q33370831-CD3D684B-1445-4255-9A20-EFAB98162195 Q33376165-71CC6718-5F9E-46C8-8CE5-08A7F92F8A77 Q33382854-8AB73CB7-244F-4A3F-AEEF-AFEEC76318DE Q33383468-BB578274-7EA5-4336-9981-F5635AF17D12 Q33384235-AB17CA60-8544-4B51-97C0-49216776AC70 Q33386133-D9DAFAE0-853C-4B23-82A1-84FAAD881AC1 Q33386712-97062C89-980F-45AF-84FF-C5342EDE8DE9 Q33387808-F15D0408-7244-4094-A17B-8999B1BED8C1 Q33388664-644533D6-095F-4428-933F-21709B0CD9CA Q33394544-2C0E1134-5401-44E2-ABC9-9967DFADCAC8 Q33394547-C64515EE-61B5-44DB-902C-FB3C622B359A Q33395500-4BC78C44-B676-4B70-BB75-092CADFC128B Q33402513-15E65824-AB0A-4662-B194-A4D01CA9E965 Q33402517-AE2F1038-DF80-408C-A41D-A3800B8AAAF7 Q33412382-A5C96266-1076-43AD-978D-637B0F45DC21 Q33412844-7785105E-2CB8-47C5-AA72-B37293CF4842 Q33414386-00DFA36E-8BF7-4DC4-9BB8-7CF545FB7FF0 Q33417667-36CECC5C-8E35-4C85-BAD2-DB9AF6F294FD Q33418387-4DEDD9B8-D187-4B3E-BB68-B90E046CBE1A Q33421032-B0D34A81-6093-4455-B635-FF468F77832F Q33424123-316EC7ED-F50F-4F2A-83CB-B086AF02A82D Q33441776-93BB325D-C4FA-4D71-B1DF-60F9EEC3C9C9 Q34538771-20BEE66E-F18E-4C49-8B28-14A8B6E845E0 Q35507769-75A2421C-C146-4AED-9CBA-FD94DCB5DC6F Q35642328-B8B9D08B-3BB9-4C66-8EE5-FB25EF0CC1B2 Q35731058-2939F7EE-0267-4422-BAEC-AA986E723867 Q35936934-936F53B6-E6A4-4008-81D8-3FDB69C0E13A Q37887065-8C80C6DE-9E20-44FE-B2DE-0094E458FD32 Q38690661-7C1C6489-FCEA-4611-AB23-2660737F0011 Q39452896-1FB0450D-7C6E-4119-8E13-A218CBCE31D8 Q41860936-8BC20EE6-AC4F-434B-8108-CE3D905D2395 Q43041507-B176C738-98C2-4766-9C26-A1CDDF5D88ED

P2860

Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.

http://www.wikidata.org/entity/Q33343858

description

2002 nî lūn-bûn

@nan

2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.

@ast

Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.

@en

type

label

Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.

@ast

Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.

@en

prefLabel

Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.

@ast

Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.

@en

P1433

Q33343858-26B27E77-320C-4C6C-8F50-165CD62313F4

P1476

Q33343858-E633D09D-BC8D-4B12-A3E6-E24CAD967DB3

P2093

Q33343858-0E17950D-C73A-4A44-BA15-46D9EC49ECA2

Q33343858-1B262B6B-0966-434C-A15B-8E1C305AD955

Q33343858-2040BA21-CB0E-42C8-8359-2FCB63DA7BA9

Q33343858-96346E60-D759-48FD-B25B-E88063FB652D

Q33343858-9A527AE4-EB1A-47D8-90DF-C0E4F94E0737

Q33343858-A6CCD321-46A6-409E-A8E7-F6D00FF950CB

P2860

Q33343858-08C2C0CB-B1CF-401E-8A65-FAF7CBF0E0D7

Q33343858-18B3DC87-0EF3-42E2-87C8-589A802D4131

Q33343858-21F8CDD9-3A55-4A54-91C6-1E5EBBD8E46D

Q33343858-5E471A85-E89C-4424-90EA-6F9FB591CDDC

Q33343858-6C91DFAA-B0B2-4096-AAD5-A5E5838848BC

Q33343858-7DBB945F-2F80-434C-A825-F57701716400

Q33343858-93E76F5B-7422-4B4E-9F29-D2AC7A9136FB

Q33343858-9BD3674E-7744-435D-AB02-7CDD6F698B0D

Q33343858-A0D4D6D0-AA74-46AC-AE7F-6CEB5C84B986

Q33343858-F949AE4F-3B3C-4FC0-B815-8A7AEC74C77C

P304

Q33343858-9ECD0D06-6414-4E52-BF15-9AEA85455FB2

P31

Q33343858-4C9FDA5D-CEE8-4389-B5DB-1EFA36BF618F

P356

Q33343858-3725A042-6EA4-4126-9753-4FB974803D0D

P407

Q33343858-FC7E9659-690A-432E-B0C6-040C3FB52C4F

P433

Q33343858-1A99FD1C-564F-4F60-B56A-400777E9FDAD

P478

Q33343858-B2DB30F4-C5B9-46E8-ADA6-64831789A98A

P577

Q33343858-2383E818-4B61-4621-9177-C6B1189EB1B1

P698

Q33343858-9491DCCB-B8CA-481F-B15F-DCFB201E85BA

P921

Q33343858-A744DA2C-7345-4666-AB53-42ECC957CB23

P356

J.1572-0241.2002.05845.X

P1433

The American Journal of Gastroenterology

P1476

Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection.

@en

P2093

Andrea Duchini

http://www.w3.org/2001/XMLSchema#string

Eric Viernes

http://www.w3.org/2001/XMLSchema#string

John McHutchison

http://www.w3.org/2001/XMLSchema#string

Lisa M Nyberg

http://www.w3.org/2001/XMLSchema#string

Paul J Pockros

http://www.w3.org/2001/XMLSchema#string

Robert McMillan

http://www.w3.org/2001/XMLSchema#string

P2860

Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection

Hepatitis C virus infection and autoimmune thrombocytopenic purpura.

High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders.

Thrombocytopenia associated with hepatitis C viral infection.

Immunologic thrombocytopenic purpura as presenting symptom of hepatitis C infection.

Autoimmune thrombocytopenia associated with hepatitis C virus infection.

Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease.

Cryoglobulinaemia and hepatitis C virus.

Immunological disorders in C virus chronic active hepatitis: a prospective case-control study.

Immune complex mediated vasculitis in hepatitis B and C infections and the effect of antiviral therapy.

P304

2040-2045

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1572-0241.2002.05845.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12190174

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia